Two Companies Restart Virus Trials in U.S. After Safety Pauses
Late-stage coronavirus vaccine trials run by AstraZeneca and Johnson & Johnson have resumed in the United States after the companies said on Friday that serious illnesses in a few volunteers appeared not to be related to the vaccines. Federal health regulators gave AstraZeneca the green light after a six-week pause, concluding there was no evidence…